Import Bipap Non-Invasive Ventilator — Buy in wholesale FOB from Supplier in Estonia

Aiia International Ou supplies a BiPAP non-invasive ventilator from Estonia intended for adult and paediatric patients with acute respiratory distress syndrome managed through non-invasive or high-flow oxygen systems. The device provides biphasic positive airway pressure ventilation, delivering separate inspiratory and expiratory pressure settings to support spontaneous breathing without endotracheal intubation. According to the listing, the ventilator is suitable for medical institutions and home-based cardiopulmonary resuscitation respiratory support, covering indications including acute respiratory failure with incomplete oxygenation, carbon dioxide retention, and post-operative respiratory support. The supplier states that partner products hold international certification with complete test reports, and that production includes quality control at every stage.

The BiPAP ventilator operates as a non-invasive ventilation (NIV) platform, meaning it interfaces with the patient via nasal mask, full-face mask, or helmet rather than invasive airway. Key technical considerations for buyers include pressure range (typically 4-30 cmH2O for IPAP and 2-20 cmH2O for EPAP in comparable devices), breath rate triggering sensitivity, inspiratory/expiratory time ratio, and oxygen blending capability. The listing notes suitability for high-flow oxygen systems, suggesting integration with heated humidified high-flow nasal cannula or oxygen source blending. Battery backup duration, alarm parameters (apnoea, disconnect, power failure), and data logging capability are not specified and require direct confirmation with Aiia International Ou.

Target buyers include hospital procurement departments, intensive care units, respiratory therapy departments, home medical equipment providers, and government health agencies building pandemic or emergency response stockpiles. The reference to COVID-19 patient suitability indicates positioning for surge capacity and alternative care site deployment. Regulatory pathway depends on destination market, whether EU MDR/CE marking, FDA 510(k), or national emergency use authorisation. Pricing, minimum order quantity, warranty terms, and lead time are not disclosed in the listing and must be negotiated directly. Estonia's location offers EU regulatory alignment with potential logistics advantages for European buyers.

Aiia International Ou is registered at Peterburi Tee 47, Tallinn 11415, Estonia, placing it in the Baltic region with EU regulatory framework applicability. The company operates as a supplier of medical devices, specifically ventilatory support equipment, with stated international certification for partner-manufactured products. The trust tier is listed as harbor. Response rate and average response hours both show zero, indicating no platform enquiry history or unrecorded engagement. No information is provided about company size, year of establishment, annual turnover, number of employees, or specific manufacturing partnerships.

The listing describes Aiia International Ou's role as a supplier of partner-produced ventilators rather than original equipment manufacturer, implying distributor or trading company status. No details are given about after-sales service infrastructure, spare parts inventory, technical training provision, or clinical application support. Buyers should verify whether Aiia International Ou holds EU MDR authorised representative status, medical device distribution licence, and whether they offer installation, commissioning, and user training. The address in Tallinn suggests potential access to Estonian and broader EU logistics, though warehousing and stockholding capacity are not stated.